Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Alpha-synuclein co-pathology in Down syndrome-associated Alzheimer's disease

  • Bernhardt, Alexander Maximilian
  • Rodríguez-Baz, Íñigo|||0000-0003-3039-9115
  • Aldecoa, Iban|||0000-0001-5774-7453
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Arriola Infante, José Enrique|||0000-0002-3298-4601
  • Maure Blesa, Lucia|||0000-0001-5643-7971
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Longen, Sebastian
  • Trossbach, Svenja Verena
  • Giese, Armin
  • Matthias, Torsten
  • Benejam, Bessy|||0000-0002-6789-8615
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Hoyo Soriano, Laura del|||0000-0003-4372-1599
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Sanjuan, Aída
  • Fernández, Susana|||0000-0002-9777-1156
  • Vaqué-Alcázar, Lídia|||0000-0002-6776-6559
  • Aranha, Mateus|||0000-0001-9594-292X
  • Morcillo Nieto, Alejandra O.|||0000-0003-2202-3521
  • Nübling, Georg|||0000-0003-4492-7302
  • Wagemann, Olivia
  • Stockbauer, Anna
  • Tondo Colomer, Mireia|||0000-0002-0301-9984
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Lleó, Alberto|||0000-0002-2568-5478
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Molina-Porcel, Laura|||0000-0003-4068-8578
  • Fortea, Juan|||0000-0002-1340-638X
  • Levin, Johannes|||0000-0001-5092-4306
Alpha-synuclein (αSyn) seed amplification assay (SAA) enables in vivo study of αSyn but remains underexplored in Down syndrome-associated Alzheimer's disease (DSAD). We analyzed αSyn-SAA in cerebrospinal fluid (CSF) from 270 adults with Down syndrome, from the Down Alzheimer Barcelona Neuroimaging Initiative and from the AD21 cohort from the Department of Neurology at the University Hospital, Ludwig Maximilian University of Munich, Germany. Neuropathological examinations were conducted in 19 brain donors (five with ante mortem CSF). Participants were classified as asymptomatic or symptomatic (prodromal/dementia) Alzheimer's disease (AD). CSF Aβ1-42/1-40, CSF and plasma p-Tau181, and neurofilament light chain (NfL) levels were measured. Neuropathological evaluations assessed AD neuropathological changes and Lewy body pathology (LBP). ΑSyn-SAA was positive in 9.2% of cases, independent of age or cognitive status. Symptomatic αSyn-positive cases exhibited higher plasma NfL levels than αSyn-negative cases (31 vs 21 pg/mL, p = 0.027). LBP was observed in 47% of necropsies. The individual with severe neocortical LBP was αSyn-SAA-positive. These findings highlight LBP prevalence in DSAD but suggest current SAA may fail to detect limited αSyn deposition.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Subcutaneous administration of an endocrine-mimetic platform allows for prolonged tumor uptake of a tumor targeting protein

  • Álamo, Patricia|||0000-0003-0510-5701
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Favaro, Marianna T.P.|||0000-0003-2942-247X
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Vázquez, Esther|||0000-0003-1052-0424
Endocrine-like dynamic protein depots can be fabricated in vitro through the coordination of divalent zinc ions (Zn) with solvent-exposed histidine residues on functional proteins, leading to their controlled aggregation. The resulting microparticles, under physiological conditions, undergo progressive disintegration due to spontaneous Zn dilution, enabling a time-sustained release of the protein components. These chemically pure protein-based materials represent promising drug delivery platforms, with demonstrated efficacy in oncology, vaccinology, tissue regeneration, and antibacterial therapies. To enable systemic delivery of the embedded protein, alternative administration routes are potentially suited, but their effectiveness in terms of biodistribution and accumulation in target tissues remains unexplored. Using a CXCR4 cancer mouse model, we investigated the tumor targeting and permanence of a self-assembling, CXCR4-binding fluorescent protein administered in the form of secretory granules via subcutaneous, intramuscular, or intraperitoneal injection. Our data reveal that subcutaneous administration supports prolonged protein retention at the injection site, its release within the local draining lymphatic vessels, extended circulation time, and significantly higher tumor accumulation 10 days post-injection. Compared to intramuscular and intraperitoneal routes, the subcutaneous pathway presents clear advantages, potentially allowing reduced dosing frequency in protein-based therapies aimed at maintaining steady systemic and target tissue levels.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Blood speckle imaging for the assessment of aortic valve velocity in healthy children, Reproducibility and comparison with Doppler echocardiography

  • Freixa-Benavente, Andrea|||0000-0001-9235-1788
  • Garrido-Oliver, Juan|||0000-0002-5806-2031
  • Roses Noguer, Ferran|||0000-0002-5955-7490
  • Dux-Santoy, Lydia|||0000-0001-8736-2095
  • Guala, Andrea|||0000-0002-5006-8164
  • Rodríguez Palomares, José Fernando|||0000-0002-8822-5532
  • Sabaté-Rotés, Anna|||0000-0002-3127-7673
Introduction: Blood speckle imaging (BSI) in paediatrics is a promising novel echocardiography technique that allows complex blood flow assessment via qualitative visualization and analysis of vorticity, energy loss and kinetic energy. However, velocity quantification using BSI has scarcely been studied in vivo. Methodology: Maximum aortic valve velocities by conventional Doppler echocardiography were compared with those derived from BSI in healthy children. BSI-derived velocities were extracted via a custom Python code. Agreement between methods was assessed using Pearson correlation and Bland-Altman analysis. Inter-observer reproducibility of BSI analysis was evaluated in a randomly selected subset. Results: Seventy-seven Doppler acquisitions from 33 patients were analysed. The median age was 84 months, and maximum velocity was 1.19 m/s. Modest correlation (R = 0.53, p-value<0.001) was found between BSI and Doppler velocities. Age-stratified analysis showed good correlation in younger children (<6.5 years; R = 0.59, p-value<0.001), whereas no significant correlation was found in older subjects. A non-significant trend towards BSI underestimating velocities, more marked in older children, was noted. Discrepancies between methods increased at higher velocities. Inter-observer reproducibility of BSI velocities was good (R = 0.7, p-value = 0.006). Discussion and conclusion: Aortic valve velocities by BSI technique show moderate correlation with Doppler in healthy children, with better performance in younger subjects, and good inter-observer reproducibility. Overall, the findings support BSI echocardiography for aortic valve maximum velocity assessment in healthy children, but further research is warranted to determine its utility in patients with aortic valve disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates

  • Rueda, Ariana|||0000-0001-7588-9279
  • Garcia León, Annabel|||0000-0003-3007-9306
  • Arena, Lourdes Ailen|||0009-0006-1863-3895
  • Mendoza, Julian Ignacio|||0000-0002-1975-3606
  • Aviñó, Ana|||0000-0003-3047-738X
  • Fabrega, Carme|||0000-0003-3816-7634
  • Eritja, Ramon|||0000-0001-5383-9334
  • Paez, David|||0000-0002-5596-6588
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
Precision targeting is a hot topic in cancer nanomedicine, as conventional chemotherapies cause systemic toxicities, creating an urgent need for more selective treatments. Although antibody-drug conjugates (ADCs) are the current gold standard in targeted therapy, their clinical performance remains limited. As an alternative, we previously developed a multivalent protein nanocarrier (T22-GFP-H6) displaying the CXCR4-targeting peptide T22, which offers super-selective tumor accumulation driven by CXCR4 overexpression. This innovative nanovehicle showed favorable biodistribution for targeted delivery of antitumor drugs, including monomethyl auristatin E (MMAE), in a first-generation stochastic nanoconjugate format. However, unlike ADCs, where conjugation strategy is known to influence pharmacokinetics and efficacy, these parameters remain largely unexplored in non-antibody multivalent nanocarriers. Here, we evaluated the impact of precise payload accommodation using two site-specific strategies that attach a single MMAE molecule at distinct structural sites, and we compared them with first-generation nanoconjugates. The conjugation strategy substantially affected the biodistribution and antitumor efficacy, with a solvent-exposed cysteine-conjugation distal to the targeting ligand proving most effective. At equimolar nanocarrier dosing, this construct achieved tumor control similar to the stochastic conjugate in a disseminated hematologic malignancy despite an approximately 4-fold lower MMAE load (drug-to-protein ratio, DPR = 1 vs DPR ≈ 4). Moreover, at equimolar MMAE dosing, it clearly outperformed both the stochastic conjugate and the alternative site-directed design. These findings align with trends in advanced ADCs and provide practical design rules for rational, site-specific conjugation in next-generation protein-based nanomedicines aimed at enabling dose-sparing in oncology.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

KDEL-mediated modulation of intracellular trafficking in cell-targeted protein drugs

  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Arena, Lourdes Ailen|||0009-0006-1863-3895
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
The biological activity of therapeutic proteins, upon intracellular delivery, is dramatically minimized by lysosomal proteolytic digestion. This is a limitation when developing cell-targeted pharmaceuticals that penetrate target cells via receptor recognition and endosomal engulfment. Since proteins benefit from functional and conformational versatility, editable by genetic engineering, endosomolytic protein domains are often fused to the functional polypeptide to promote their cytosolic delivery, aiming at minimizing proteolysis in mature lysosomes. This straightforward strategy has, however, rendered irregular results, linked to the fusogenic nature of most of the tested domains. Alternatively, proteolysis of protein drugs might be controlled by bypassing the lysosomal route, forcing an unconventional traffic of the uptaken protein material to be secreted from the endoplasmic reticulum (ER). This possibility, used in nature by several plant and microbial proteins, has been evaluated here by functionalizing a protein-only antitumoral drug, based on a cell-targeted diphtheria toxin, with a C-terminal KDEL motif. Thus, if KDEL were able to reprogram the intracellular trafficking, KDEL-tagged cell delivered proteins would be expected to avoid the lysosomal degradation, resulting in enhanced stability and activity. The obtained results validate this hypothesis and point out KDEL as a promising functional agent in cell-targeted protein drugs.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Precision targeting of CXCR4+ leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model

  • Garcia León, Annabel|||0000-0003-3007-9306
  • Mendoza, Julian Ignacio|||0000-0002-1975-3606
  • Rueda, Ariana|||0000-0001-7588-9279
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Sierra, Jorge|||0000-0002-7966-0356
  • Garrido Diaz, Ana|||0000-0002-5297-8946
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
Acute myeloid leukemia (AML) presents major clinical challenges due to chemoresistance and high relapse rates, primarily driven by therapy-resistant leukemic stem cells (LSCs) within the bone marrow. To address this issue, we developed T22-HSNBT-H6-MMAE, a novel humanized nanoconjugate designed to target CXCR4 cells while delivering the cytotoxic payload monomethyl auristatin E (MMAE). CXCR4 signaling pathway plays a critical role in LSC survival by preserving stem-like properties and activating protective mechanisms that promote treatment resistance. Moreover, CXCR4 is overexpressed in approximately 50 % of AML patients and is associated with poor prognosis and high relapse rates. We evaluated the therapeutic potential of T22-HSNBT-H6-MMAE using in vitro assays with AML cell lines and primary patient samples, as well as in vivo studies in a disseminated AML mouse model. Our results demonstrated that T22-HSNBT-H6-MMAE exerts a CXCR4-dependent cytotoxic effect through mitotic catastrophe and apoptosis induction in CXCR4 AML cell lines. In vivo evaluation in a disseminated CXCR4 AML mouse model showed potent antineoplastic activity, with complete suppression of leukemic dissemination and significantly prolonged survival, all without systemic toxicity. Notably, the nanoconjugate remained effective even in models with extensive bone marrow involvement and exhibited activity against diverse patient-derived CXCR4 AML blasts, while sparing healthy donor bone marrow and peripheral blood mononuclear cells (PBMCs) from significant toxicity. Collectively, these findings highlight T22-HSNBT-H6-MMAE as a promising therapeutic candidate for a broad range of AML patients, offering selective antineoplastic activity against CXCR4 leukemic cells.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Overcoming Antifungal Resistance: A Histatin 5-Gated Nanodevice for On-Demand Surfactant Delivery against Infections

  • Reyes-Torres, Miguel|||0000-0003-4751-2698
  • Hicke-García, Francisco Javier|||0000-0002-8419-0467
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Sanz-Álvarez, Víctor|||0009-0004-7967-6552
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • de Boer, Leonie
  • Zaat, Sebastian A. J.
  • Diez-Sánchez, Paula
[EN] The escalating incidence of fungal infections, coupled with the emergence of antifungal resistance, represents a formidable global public health challenge. is a common opportunistic fungus that causes life-threatening, widespread candidiasis, especially in immunocompromised patients. Conventional antifungals, including azoles, echinocandins, and polyenes, have some drawbacks, such as host toxicity and the rapid appearance of resistant fungal strains. To overcome these limitations, we engineered a stimuli-responsive gated antimicrobial nanoparticle using mesoporous silica nanoparticles, functionalized with the antimicrobial peptide histatin 5 (Hst5) and loaded with the surfactant (3-(methyl)-1-tetradecylimidazolium) [C14MIM]+. The nanoparticles exhibit potent antimicrobial activity against , with minimum inhibitory concentration values comparable to current clinical antifungals. Crucially, the nanodevice exhibits a dual mechanism of action, causing membrane disruption and inducing reactive oxygen species generation, which effectively hinders the development of resistance. Furthermore, the nanoparticles display strong synergistic interactions with conventional antifungals, significantly enhancing their efficacy. In addition to its planktonic activity, the system effectively inhibits biofilm formation and demonstrates high biocompatibility with human dermal cell lines. Based on these results, the nanodevice is successfully incorporated into a wound dressing matrix, demonstrating its promising translational potential for the topical treatment of cutaneous candidiasis., This research was supported by projects PID2021-126304OB-C41, PID2021-128141OB-C22, PID2024-155683OB-C41, and PID2024-162542OB-I00 funded by MCIN/AEI/10.13039/501100011033/ and by European Regional Development Fund-a way of funding Europe. This work was also supported by the European Research Council (ERC) via Advanced Grant (101,052,997, EDISON). This study formed part of the Advanced Materials program (MFA/2022/053) and the AGROALNEXT program (AGROALNEXT/2022/032), supported by MCIN with funding from the European Union NextGenerationEU (PRTR-C17 & centerdot;I1) and by Generalitat Valenciana. The study was also supported by Generalitat Valenciana (CIPROM/2021/007). This research was supported by CIBER, Consorcio Centro de Investigacion Biomedica en Red (CB06/01/2012). M.R.-T. thanks MIU for his FPU grant (FPU21/03142). F.J.H. thanks Ministerio de Universidades (MIU, Spanish Government) for his FPU grant (FPU20/06021). P.D. thanks the Instituto de Salud Carlos III and the European Social Fund for financial support "Miguel Servet" (CP24/00043).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Iridium Nanoparticle-Gated Janus Nanomachines for Enzyme-Controlled Drug Delivery

  • Mayol, Beatriz
  • Gonzalez-Jimenez, Marta
  • Sanchez, Alfredo
  • Portela, Susana
  • Pradana-López, Sandra
  • Moreno, Teresa
  • Cai, RuiYuan
  • Martinez-Ruiz, Paloma
  • Martinez-Quiles, Narcisa
  • Diez-Sánchez, Paula
  • Ojeda, Irene
  • Vilela, Diana
  • Villalonga, Reynaldo
  • López-Benet, Carolina
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Controlled drug delivery systems (DDSs) have emerged as a promising alternative to conventional therapies, aiming to optimize drug release profiles and improve therapeutic outcomes while reducing systemic side effects. In this work, iridium-gated Janus nanomachines are proposed as enzyme-regulated platforms for smart and autonomous drug delivery. These hybrid nanostructures consist of mesoporous silica nanoparticles asymmetrically functionalized with gold nanoparticles bearing surface-anchored enzymes on the metallic hemisphere, while the opposite mesoporous face incorporates pH-responsive molecular gates based on aminophenylboronic acid and d-lactose-functionalized iridium nanoparticles, enabling efficient cargo loading and motility behavior. To evaluate nanomachine operation, two enzymatic systems were employed: glucose oxidase (GOx) and a tandem esterase/alcohol oxidase (AOX) system, using spectrophotometric monitoring of the model cargo release. Both platforms exhibited well-defined release kinetics and good correlation between substrate concentration and high selectivity toward their respective inputs. Motility studies revealed the appearance of two particle populations in the presence of glucose or methanol, consistent with enhanced motion driven by catalytic reactions at the iridium nanoparticle surface upon enzymatic hydrogen peroxide generation. Finally, the GOx-based nanomachine loaded with the antitumoral drug doxorubicin (DOXO) demonstrated efficient cellular internalization, preserved biocompatibility, and enhanced antitumoral activity in HeLa cells. Overall, this work reinforces the potential of enzyme-controlled Janus nanomachines as multifunctional platforms integrating autonomous motion and stimulus-responsive drug delivery for advanced therapeutic applications., Financial support from the Spanish Ministry of Economy and Competitiveness (projects CTQ2017-87954-P and PID2021-125723NB-I00), the Spanish Ministry of Science and Innovation (projects CNS2022-135255 and PID2024-155683OB-C41), and the European Research Council (ERC) via Advanced Grant (101052997, EDISON) is gratefully acknowledged. I.O. thanks the financial support from the regional government of Madrid and Complutense University (PR17/24-31938). M.G. also thanks the Public Employment Service (SEPE) and NextGenerationEU funds for financial support through the Investigo Program (CT19/23-INVM-56) and the Community of Madrid and the European Social Fund Plus (ESF+) CT3/25/PEJ-2024-AI/BIO-32377. T.M. also thanks the Spanish Ministry of Education, Vocational Training and Sports for the Collaboration Grant BDNS-764344. P.D. and S.P.-L. thank the Instituto de Salud Carlos III and the European Social Fund for financial support "Miguel Servet" (CP24/00043) and "Sara Borrell" (CD24/00075), respectively. C.L-B also thanks UPV for her predoctoral grant (PAID-01-25).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Natural antimicrobials synergistically coupled with nanomotors: An innovative strategy for biofilm eradication

  • Medaglia, Serena|||0000-0003-3537-9842
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • Hicke-García, Francisco Javier|||0000-0002-8419-0467
  • Reyes-Torres, Miguel|||0000-0003-4751-2698
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marin-Ferrandis, Lucia
  • Amorós, Pedro
  • Marcos, MD
  • Diez-Sánchez, Paula
[EN] Biofilms are one of the most important problems occurring in industrial environments, especially in food industry. The possibility of foodborne disease outbreaks as a result of biofilm-food cross-contamination is a distinct concern, along with the substantial costs associated with food spoilage and biofilm control. Besides, despite daily cleaning and disinfection, many bacteria grow in machines and surfaces in food processing plants, some of them forming biofilms. A promising procedure for disinfection and biofilm elimination could be the use of hybrid antimicrobial nanomaterials endowed with motion (i.e., nanomotors). Herein, we report Janus nanoparticles based on the conjunction of platinum and mesoporous silica nanoparticles, functionalized with a derivative of a natural antimicrobial compound, vanillin. The engineered nanomotors combine H2O2-triggered self-propulsion with the antimicrobial activity of vanillin, allowing enhanced physical penetration into the 3D matrix formed by the exopolymeric substances generated in monospecies (Staphylococcus aureus) and multispecies (S. aureus and Escherichia coli) biofilms and the subsequent elimination of pathogenic cells., The Spanish Government (projects PID2021-126304OB-C41, PID2021-128141OB-C22 and TED2021-132114B-I00, MCUI/FEDER, EU and CIBER-Consorcio Centro de Investigacion Biomedica en Red (CB06/01/2012) , Instituto de Salud Carlos III, Ministerio de Ciencia Innovacion) and the Generalitat Valenciana (CIPROM/2021/007) funded this research. This work was also supported by the European Research Council (ERC) via Advanced Grant (101,052,997, EDISON) . This study formed part of the Advanced Materials program (MFA/2022/053) and the AGROALNEXT program (AGROALNEXT/2022/032) , supported by MCIN with funding from the European Union NextGenerationEU (PRTR-C17 & sdot;I1) and by Generalitat Valenciana. S.M. thanks the Generalitat Valenciana for her Grisolia fellowship (GRISOLIAP/2018/149) . A<acute accent>.M.-A. thanks the Universitat Politecnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22) . F.J.H thanks Ministerio de Universidades (MIU, Spanish Government) for his FPU grant (FPU20/06021) . M.R.-T. thanks MIU for his FPU grant (FPU21/03142) . A.B. thanks the MIU for her Beatriz Galindo contract (BG20/00020) . P.D.thanks the Instituto de Salud Carlos III and the European Social Fund for financial support "Sara Borrell" (CD20/00120) and "Miguel Servet" (CP24/00043) .